• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA:衰老肾脏及肾脏疾病的双刃剑。

Long non-coding RNAs: A double-edged sword in aging kidney and renal disease.

机构信息

Faculty of Life Science & Medicine, Northwest University, No. 229 Taibai North Road, Xi'an, Shaanxi, 710069, China.

Department of Nephrology, Shaanxi Traditional Chinese Medicine Hospital, No. 2 Xihuamen, Xi'an, Shaanxi, 710003, China.

出版信息

Chem Biol Interact. 2021 Mar 1;337:109396. doi: 10.1016/j.cbi.2021.109396. Epub 2021 Jan 25.

DOI:10.1016/j.cbi.2021.109396
PMID:33508306
Abstract

Aging as one of intrinsic biological processes is a risk factor for many chronic diseases. Kidney disease is a global problem and health care burden worldwide. The diagnosis of kidney disease is currently based on serum creatinine and urea levels. Novel biomarkers may improve diagnostic accuracy, thereby allowing early prevention and treatment. Over the past few years, advances in genome analyses have identified an emerging class of noncoding RNAs that play critical roles in the regulation of gene expression and epigenetic reprogramming. Long noncoding RNAs (lncRNAs) are pervasively transcribed in the genome and could bind DNA, RNA and protein. Emerging evidence has demonstrated that lncRNAs played an important role in all stages of kidney disease. To date, only some lncRNAs were well identified and characterized, but the complexity of multilevel regulation of transcriptional programs involved in these processes remains undefined. In this review, we summarized the lncRNA expression profiling of large-scale identified lncRNAs on kidney diseases including acute kidney injury, chronic kidney disease, diabetic nephropathy and kidney transplantation. We further discussed a number of annotated lncRNAs linking with complex etiology of kidney diseases. Finally, several lncRNAs were highlighted as diagnostic biomarkers and therapeutic targets. Targeting lncRNAs may represent a precise therapeutic strategy for progressive renal fibrosis.

摘要

衰老是一种内在的生物学过程,是许多慢性疾病的危险因素。肾脏疾病是一个全球性的问题,也是全球的健康负担。目前,肾脏疾病的诊断基于血清肌酐和尿素水平。新型生物标志物可能会提高诊断的准确性,从而可以进行早期预防和治疗。在过去的几年中,基因组分析的进展已经确定了一类新的非编码 RNA,它们在基因表达和表观遗传重编程的调控中发挥着关键作用。长链非编码 RNA (lncRNA) 在基因组中广泛转录,并能与 DNA、RNA 和蛋白质结合。新出现的证据表明,lncRNA 在肾脏疾病的所有阶段都发挥着重要作用。迄今为止,只有一些 lncRNA 被很好地识别和描述,但涉及这些过程的转录程序的多层次调控的复杂性仍未确定。在这篇综述中,我们总结了大规模鉴定的 lncRNA 在急性肾损伤、慢性肾脏病、糖尿病肾病和肾移植等肾脏疾病中的表达谱。我们进一步讨论了一些与肾脏疾病复杂病因相关的注释 lncRNA。最后,有几个 lncRNA 被强调为诊断生物标志物和治疗靶点。针对 lncRNA 可能代表一种针对进行性肾纤维化的精确治疗策略。

相似文献

1
Long non-coding RNAs: A double-edged sword in aging kidney and renal disease.长链非编码 RNA:衰老肾脏及肾脏疾病的双刃剑。
Chem Biol Interact. 2021 Mar 1;337:109396. doi: 10.1016/j.cbi.2021.109396. Epub 2021 Jan 25.
2
Potential Roles of Long Noncoding RNAs as Therapeutic Targets in Renal Fibrosis.长链非编码 RNA 作为肾脏纤维化治疗靶点的潜在作用。
Int J Mol Sci. 2020 Apr 13;21(8):2698. doi: 10.3390/ijms21082698.
3
Interactions among Long Non-Coding RNAs and microRNAs Influence Disease Phenotype in Diabetes and Diabetic Kidney Disease.长链非编码RNA与微小RNA之间的相互作用影响糖尿病及糖尿病肾病的疾病表型。
Int J Mol Sci. 2021 Jun 2;22(11):6027. doi: 10.3390/ijms22116027.
4
Long noncoding RNAs in the pathogenesis of diabetic kidney disease: implications for novel therapeutic strategies.长链非编码RNA在糖尿病肾病发病机制中的作用:对新型治疗策略的启示
Per Med. 2017 May;14(3):271-278. doi: 10.2217/pme-2016-0107. Epub 2017 May 5.
5
Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease.长链非编码 RNA:在糖尿病和糖尿病肾病中的新兴角色。
Clin Sci (Lond). 2019 Jun 20;133(12):1321-1339. doi: 10.1042/CS20190372. Print 2019 Jun 28.
6
Microarray analysis of long noncoding RNA expression patterns in diabetic nephropathy.糖尿病肾病中长链非编码RNA表达模式的微阵列分析
J Diabetes Complications. 2017 Mar;31(3):569-576. doi: 10.1016/j.jdiacomp.2016.11.017. Epub 2016 Dec 8.
7
Long Noncoding RNAs and Their Therapeutic Promise in Diabetic Nephropathy.长链非编码 RNA 及其在糖尿病肾病中的治疗潜力。
Nephron. 2021;145(4):404-414. doi: 10.1159/000515422. Epub 2021 Apr 14.
8
Long non-coding RNAs: An essential emerging field in kidney pathogenesis.长非编码 RNA:肾脏发病机制中一个必不可少的新兴领域。
Biomed Pharmacother. 2018 Mar;99:755-765. doi: 10.1016/j.biopha.2018.01.122. Epub 2018 Feb 20.
9
Long non-coding RNA ENSMUST00000147869 protects mesangial cells from proliferation and fibrosis induced by diabetic nephropathy.长链非编码RNA ENSMUST00000147869可保护系膜细胞免受糖尿病肾病诱导的增殖和纤维化影响。
Endocrine. 2016 Oct;54(1):81-92. doi: 10.1007/s12020-016-0950-5. Epub 2016 Apr 15.
10
A systematic review of epigenetic interplay in kidney diseases: Crosstalk between long noncoding RNAs and methylation, acetylation of chromatin and histone.系统综述肾脏疾病中的表观遗传相互作用:长非编码 RNA 与染色质甲基化、乙酰化和组蛋白之间的串扰。
Biomed Pharmacother. 2024 Jul;176:116922. doi: 10.1016/j.biopha.2024.116922. Epub 2024 Jun 12.

引用本文的文献

1
The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis.核因子κB信号通路是肾纤维化的主要调节因子。
Front Pharmacol. 2024 Jan 16;14:1335094. doi: 10.3389/fphar.2023.1335094. eCollection 2023.
2
Exploring the Therapeutic Significance of microRNAs and lncRNAs in Kidney Diseases.探索微小RNA和长链非编码RNA在肾脏疾病中的治疗意义。
Genes (Basel). 2024 Jan 19;15(1):123. doi: 10.3390/genes15010123.
3
How can we modulate aging through nutrition and physical exercise? An epigenetic approach.我们如何通过营养和体育锻炼来调节衰老?一种表观遗传学方法。
Aging (Albany NY). 2023 Apr 20;15(8):3191-3217. doi: 10.18632/aging.204668.
4
Kidney diseases and long non-coding RNAs in the limelight.备受关注的肾脏疾病与长链非编码RNA
Front Physiol. 2022 Oct 10;13:932693. doi: 10.3389/fphys.2022.932693. eCollection 2022.
5
Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy.膜性肾病:基于系统生物学的新机制与中医药治疗
Front Pharmacol. 2022 Sep 13;13:969930. doi: 10.3389/fphar.2022.969930. eCollection 2022.
6
Recent Advances in Epigenetics of Age-Related Kidney Diseases.衰老相关肾脏疾病的表观遗传学最新进展
Genes (Basel). 2022 Apr 29;13(5):796. doi: 10.3390/genes13050796.
7
TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis.肾小管间质纤维化中的转化生长因子-β/信号转导和转录激活因子信号通路
Front Pharmacol. 2022 Mar 24;13:860588. doi: 10.3389/fphar.2022.860588. eCollection 2022.
8
Epigenetic Changes and Functions in Pneumoconiosis.尘肺的表观遗传改变与功能。
Oxid Med Cell Longev. 2022 Jan 20;2022:2523066. doi: 10.1155/2022/2523066. eCollection 2022.
9
Long Noncoding RNA ZFAS1 Protects HK-2 Cells against Sepsis-Induced Injury through Targeting the miR3723p/PPAR Axis.长链非编码 RNA ZFAS1 通过靶向 miR3723p/PPAR 轴保护 HK-2 细胞免受脓毒症诱导的损伤。
J Healthc Eng. 2022 Jan 7;2022:7768963. doi: 10.1155/2022/7768963. eCollection 2022.
10
Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IƙB/NF-ƙB and Keap1/Nrf2 Signaling Pathways.参康注射液及其三种蒽醌类化合物通过同时靶向IκB/NF-κB和Keap1/Nrf2信号通路改善肾纤维化。
Front Pharmacol. 2021 Dec 22;12:800522. doi: 10.3389/fphar.2021.800522. eCollection 2021.